miR-30c-2-3p suppresses the proliferation of human renal cell carcinoma cells by targeting TOP2A

[1] Tao H, Li Z, Mei Y, Li X, Lou H, Dong L, Zhou L. Integrative bioinformatics analysis of a prognostic index and immunotherapeutic targets in renal cell carcinoma. Int Immunopharmacol. 2020; 87:106832. doi: 10.1016/j.intimp.2020.106832 TaoH LiZ MeiY LiX LouH DongL ZhouL Integrative bioinformatics analysis of a prognostic index and immunotherapeutic targets in renal cell carcinoma Int Immunopharmacol 2020 87 106832 10.1016/j.intimp.2020.106832 Open DOISearch in Google Scholar

[2] Monteiro MS, Barros AS, Pinto J, Carvalho M, Pires-Luís AS, Henrique R, et al. Nuclear magnetic resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma. Sci Rep. 2016; 6:37275. doi: 10.1038/srep37275 MonteiroMS BarrosAS PintoJ CarvalhoM Pires-LuísAS HenriqueR Nuclear magnetic resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma Sci Rep 2016 6 37275 10.1038/srep37275 Open DOISearch in Google Scholar

[3] Meng H, Jiang X, Cui J, Yin G, Shi B, Liu Q, et al. Genomic analysis reveals novel specific metastatic mutations in Chinese clear cell renal cell carcinoma. Biomed Res Int. 2020; 2020:2495157. doi: 10.1155/2020/2495157 MengH JiangX CuiJ YinG ShiB LiuQ Genomic analysis reveals novel specific metastatic mutations in Chinese clear cell renal cell carcinoma Biomed Res Int 2020 2020 2495157 10.1155/2020/2495157 Open DOISearch in Google Scholar

[4] Huang C, Li J, Zhang X, Xiong T, Ye J, Yu J, Gui Y. The miR-140-5p/KLF9/KCNQ1 axis promotes the progression of renal cell carcinoma. FASEB J. 2020; 34:10623–39. HuangC LiJ ZhangX XiongT YeJ YuJ GuiY The miR-140-5p/KLF9/KCNQ1 axis promotes the progression of renal cell carcinoma FASEB J 2020 34 10623 39 Search in Google Scholar

[5] Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A, Bray F. International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol. 2015; 67:519–30. ZnaorA Lortet-TieulentJ LaversanneM JemalA BrayF International variations and trends in renal cell carcinoma incidence and mortality Eur Urol 2015 67 519 30 Search in Google Scholar

[6] Chen Y, Du J, Wang Y, Shi H, Jiang Q, Wang Y, et al. MicroRNA-497-5p induces cell cycle arrest of cervical cancer cells in S phase by targeting CBX4. Onco Targets Ther. 2019; 12:10535–45. ChenY DuJ WangY ShiH JiangQ WangY MicroRNA-497-5p induces cell cycle arrest of cervical cancer cells in S phase by targeting CBX4 Onco Targets Ther 2019 12 10535 45 Search in Google Scholar

[7] Mathew LK, Lee SS, Skuli N, Rao S, Keith B, Nathanson KL, et al. Restricted expression of miR-30c-2-3p and miR-30a-3p in clear cell renal carcinomas enhances HIF2α activity. Cancer Discov. 2014; 4:53–60. MathewLK LeeSS SkuliN RaoS KeithB NathansonKL Restricted expression of miR-30c-2-3p and miR-30a-3p in clear cell renal carcinomas enhances HIF2α activity Cancer Discov 2014 4 53 60 Search in Google Scholar

[8] Tang CT, Liang Q, Yang L, Lin XL, Wu S, Chen Y, et al. RAB31 targeted by MiR-30c-2-3p regulates the GLI1 signaling pathway, affecting gastric cancer cell proliferation and apoptosis. Front Oncol. 2018; 8:554. doi: 10.3389/fonc.2018.00554 TangCT LiangQ YangL LinXL WuS ChenY RAB31 targeted by MiR-30c-2-3p regulates the GLI1 signaling pathway, affecting gastric cancer cell proliferation and apoptosis Front Oncol 2018 8 554 10.3389/fonc.2018.00554 Open DOISearch in Google Scholar

[9] Shukla K, Sharma AK, Ward A, Will R, Hielscher T, Balwierz A, et al. MicroRNA-30c-2-3p negatively regulates NF-kB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer. Mol Oncol. 2015; 9:1106–19. ShuklaK SharmaAK WardA WillR HielscherT BalwierzA MicroRNA-30c-2-3p negatively regulates NF-kB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer Mol Oncol 2015 9 1106 19 Search in Google Scholar

[10] Dougherty AC, Hawaz MG, Hoang KG, Trac J, Keck JM, Ayes C, Deweese JE. Exploration of the role of the C-terminal domain of human DNA topoisomerase IIα in catalytic activity. ACS Omega. 2021; 6:25892–903. DoughertyAC HawazMG HoangKG TracJ KeckJM AyesC DeweeseJE Exploration of the role of the C-terminal domain of human DNA topoisomerase IIα in catalytic activity ACS Omega 2021 6 25892 903 Search in Google Scholar

[11] Zhang M, Liang C, Chen Q, Yan H, Xu J, Zhao H, et al. Histone H2A phosphorylation recruits topoisomerase IIa to centromeres to safeguard genomic stability. EMBO J. 2020; 39:e101863. doi: 10.15252/embj.2019101863 ZhangM LiangC ChenQ YanH XuJ ZhaoH Histone H2A phosphorylation recruits topoisomerase IIa to centromeres to safeguard genomic stability EMBO J 2020 39 e101863 10.15252/embj.2019101863 Open DOISearch in Google Scholar

[12] Antoniou-Kourounioti M, Mimmack ML, Porter ACG, Farr CJ. The impact of the C-terminal region on the interaction of topoisomerase II alpha with mitotic chromatin. Int J Mol Sci. 2019; 20:1238. doi: 10.3390/ijms20051238 Antoniou-KourouniotiM MimmackML PorterACG FarrCJ The impact of the C-terminal region on the interaction of topoisomerase II alpha with mitotic chromatin Int J Mol Sci 2019 20 1238 10.3390/ijms20051238 Open DOISearch in Google Scholar

[13] Pei YF, Yin XM, Liu XQ. TOP2A induces malignant character of pancreatic cancer through activating β-catenin signaling pathway. Biochim Biophys Acta Mol Basis Dis. 2018; 1864:197–207. PeiYF YinXM LiuXQ TOP2A induces malignant character of pancreatic cancer through activating β-catenin signaling pathway Biochim Biophys Acta Mol Basis Dis 2018 1864 197 207 Search in Google Scholar

[14] Liu T, Zhang H, Yi S, Gu L, Zhou M. Mutual regulation of MDM4 and TOP2A in cancer cell proliferation. Mol Oncol. 2019; 13:1047–58. LiuT ZhangH YiS GuL ZhouM Mutual regulation of MDM4 and TOP2A in cancer cell proliferation Mol Oncol 2019 13 1047 58 Search in Google Scholar

[15] Wang B, Shen Y, Zou Y, Qi Z, Huang G, Xia S, et al. TOP2A promotes cell migration, invasion and epithelial–mesenchymal transition in cervical cancer via activating the PI3K/AKT signaling. Cancer Manag Res. 2020; 12:3807–14. WangB ShenY ZouY QiZ HuangG XiaS TOP2A promotes cell migration, invasion and epithelial–mesenchymal transition in cervical cancer via activating the PI3K/AKT signaling Cancer Manag Res 2020 12 3807 14 Search in Google Scholar

[16] Lyu WJ, Shu YJ, Liu YB, Dong P. Topoisomerase II alpha promotes gallbladder cancer proliferation and metastasis through activating phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway. Chin Med J (Engl). 2020; 133:2321–9. LyuWJ ShuYJ LiuYB DongP Topoisomerase II alpha promotes gallbladder cancer proliferation and metastasis through activating phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway Chin Med J (Engl) 2020 133 2321 9 Search in Google Scholar

[17] Yuan L, Zeng G, Chen L, Wang G, Wang X, Cao X, et al. Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis. Int J Biol Sci. 2018; 14:266–79. YuanL ZengG ChenL WangG WangX CaoX Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis Int J Biol Sci 2018 14 266 79 Search in Google Scholar

[18] Rezghi Barez S, Movahedian Attar A, Aghaei M. MicroRNA-30c-2-3p regulates ER stress and induces apoptosis in ovarian cancer cells underlying ER stress. EXCLI J. 2021; 20:922–34. Rezghi BarezS Movahedian AttarA AghaeiM MicroRNA-30c-2-3p regulates ER stress and induces apoptosis in ovarian cancer cells underlying ER stress EXCLI J 2021 20 922 34 Search in Google Scholar

[19] Li D, Zhang Y, Li Y, Wang X, Wang F, Du J, et al. miR-149 suppresses the proliferation and metastasis of human gastric cancer cells by targeting FOXC1. Biomed Res Int. 2021; 2021:1503403. doi: 10.1155/2021/1503403 LiD ZhangY LiY WangX WangF DuJ miR-149 suppresses the proliferation and metastasis of human gastric cancer cells by targeting FOXC1 Biomed Res Int 2021 2021 1503403 10.1155/2021/1503403 Open DOISearch in Google Scholar

[20] Guidelines Working Committee of Chinese Society of Clinical Oncology. Guidelines of Chinese Society of Clinical Oncology (CSCO). Kidney Cancer. Beijing, 2015. Guidelines Working Committee of Chinese Society of Clinical Oncology Guidelines of Chinese Society of Clinical Oncology (CSCO) Kidney Cancer Beijing 2015 Search in Google Scholar

[21] Zhang C, Qu Y, Xiao H, Xiao W, Liu J, Gao Y, et al. LncRNA SNHG3 promotes clear cell renal cell carcinoma proliferation and migration by upregulating TOP2A. Exp Cell Res. 2019; 384:111595. doi: 10.1016/j.yexcr.2019.111595 ZhangC QuY XiaoH XiaoW LiuJ GaoY LncRNA SNHG3 promotes clear cell renal cell carcinoma proliferation and migration by upregulating TOP2A Exp Cell Res 2019 384 111595 10.1016/j.yexcr.2019.111595 Open DOISearch in Google Scholar

[22] Abraham AD, Esquer H, Zhou Q, Tomlinson N, Hamill BD, Abbott JM, et al. Drug design targeting T-cell factor (TCF)-driven epithelial-mesenchymal transition as a therapeutic strategy for colorectal cancer. J Med Chem. 2019; 62:10182–203. AbrahamAD EsquerH ZhouQ TomlinsonN HamillBD AbbottJM Drug design targeting T-cell factor (TCF)-driven epithelial-mesenchymal transition as a therapeutic strategy for colorectal cancer J Med Chem 2019 62 10182 203 Search in Google Scholar

[23] Ye M, He Z, Dai W, Li Z, Chen X, Liu J. A TOP2A-derived cancer panel drives cancer progression in papillary renal cell carcinoma. Oncol Lett. 2018; 16:4169–78. YeM HeZ DaiW LiZ ChenX LiuJ A TOP2A-derived cancer panel drives cancer progression in papillary renal cell carcinoma Oncol Lett 2018 16 4169 78 Search in Google Scholar

[24] Berglund A, Amankwah EK, Kim YC, Spiess PE, Sexton WJ, Manley B, et al. Influence of gene expression on survival of clear cell renal cell carcinoma. Cancer Med. 2020; 9:8662–75. BerglundA AmankwahEK KimYC SpiessPE SextonWJ ManleyB Influence of gene expression on survival of clear cell renal cell carcinoma Cancer Med 2020 9 8662 75 Search in Google Scholar

[25] Parker AS, Eckel-Passow JE, Serie D, Hilton T, Parasramka M, Joseph RW, et al. Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma. Eur Urol. 2014; 66:929–35. ParkerAS Eckel-PassowJE SerieD HiltonT ParasramkaM JosephRW Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma Eur Urol 2014 66 929 35 Search in Google Scholar

[26] Chen D, Maruschke M, Hakenberg O, Zimmermann W, Stief CG, Buchner A. TOP2A, HELLS, ATAD2, and TET3 are novel prognostic markers in renal cell carcinoma. Urology. 2017; 102:265.e1–7. ChenD MaruschkeM HakenbergO ZimmermannW StiefCG BuchnerA TOP2A, HELLS, ATAD2, and TET3 are novel prognostic markers in renal cell carcinoma Urology 2017 102 265.e1 7 Search in Google Scholar

[27] Xiong Y, Yuan L, Chen L, Zhu Y, Zhang S, Liu X, et al. Identifying a novel biomarker TOP2A of clear cell renal cell carcinoma (ccRCC) associated with smoking by co-expression network analysis. J Cancer. 2018; 9:3912–22. XiongY YuanL ChenL ZhuY ZhangS LiuX Identifying a novel biomarker TOP2A of clear cell renal cell carcinoma (ccRCC) associated with smoking by co-expression network analysis J Cancer 2018 9 3912 22 Search in Google Scholar

[28] Zhang F, Wu H. MiR-599 targeting TOP2A inhibits the malignancy of bladder cancer cells. Biochem Biophys Res Commun. 2021; 570:154–61. ZhangF WuH MiR-599 targeting TOP2A inhibits the malignancy of bladder cancer cells Biochem Biophys Res Commun 2021 570 154 61 Search in Google Scholar

[29] Yang Z, Liu Y, Shi C, Zhang Y, Lv R, Zhang R, et al. Suppression of PTEN/AKT signaling decreases the expression of TUBB3 and TOP2A with subsequent inhibition of cell growth and induction of apoptosis in human breast cancer MCF-7 cells via ATP and caspase-3 signaling pathways. Oncol Rep. 2017; 37:1011–9. YangZ LiuY ShiC ZhangY LvR ZhangR Suppression of PTEN/AKT signaling decreases the expression of TUBB3 and TOP2A with subsequent inhibition of cell growth and induction of apoptosis in human breast cancer MCF-7 cells via ATP and caspase-3 signaling pathways Oncol Rep 2017 37 1011 9 Search in Google Scholar

[30] de Poot SA, Lai KW, van der Wal L, Plasman K, Van Damme P, Porter AC, et al. Granzyme M targets topoisomerase II alpha to trigger cell cycle arrest and caspase-dependent apoptosis. Cell Death Differ. 2014; 21:416–26. de PootSA LaiKW van der WalL PlasmanK Van DammeP PorterAC Granzyme M targets topoisomerase II alpha to trigger cell cycle arrest and caspase-dependent apoptosis Cell Death Differ 2014 21 416 26 Search in Google Scholar